What drives success for specialty pharmaceuticals?
Specialty pharmaceuticals have become increasingly important in the global pharmaceutical landscape. Numerous large pharmaceutical companies are moving towards developing therapies for specialty markets, which are attractive owing to factors including the established commercial track record and lower commercial infrastructure costs. In this article, we analyse the key drivers of commercial success and failure for specialty pharmaceuticals.
Gudiksen
Mark
M
McKinsey & Company, 3075A Hansen Way, Palo Alto, California 94304, USA.
Fleming
Edd
E
Furstenthal
Laura
L
Ma
Philip
P
D003132:Commerce; D004364:Pharmaceutical Preparations; D014481:United States
D004364:Pharmaceutical Preparations